Key Points

  • U.S. stocks closed mixed as investors weighed soft jobs data and cooling inflation against Fed rate-cut expectations.
  • Tech outperformed, with Tesla and Microsoft fueling Nasdaq’s climb to record highs.
  • Markets largely price in a 25-basis-point cut next week, though a larger move remains possible
hero

Markets Split Ahead of Fed Decision

U.S. equities ended Friday’s session on a divided note as investors grappled with a delicate balance of slowing economic momentum and rising expectations of monetary easing. The S&P 500 finished just below flat, the Dow Jones Industrial Average dropped 273 points, and the Nasdaq 100 reached fresh highs, underscoring the market’s split sentiment.

Soft labor-market data and subdued inflation reports have bolstered expectations that the Federal Reserve will cut interest rates at its September 17 policy meeting. While most traders are leaning toward a 25-basis-point move, market pricing now reflects a modest probability of a larger half-point reduction if economic conditions continue to deteriorate.

Tech Sector Drives Nasdaq to Record Levels

Technology stocks once again proved to be the market’s anchor. The Nasdaq rose 0.4% on Friday, helped by a 7.4% surge in Tesla and a 1.7% gain in Microsoft, which climbed after sidestepping a potential EU antitrust fine. The rally extended beyond these names, lifting the broader tech sector and reinforcing its dominant role in this year’s equity gains.

Consumer discretionary stocks also contributed to upside momentum, suggesting investors remain confident in selective areas of growth despite broader macroeconomic headwinds. In contrast, materials and healthcare stocks lagged, reflecting concerns over industrial demand and potential regulatory pressures in the healthcare space.

Weekly Gains Highlight Resilient Investor Sentiment

For the week, all three major indexes registered notable gains. The S&P 500 added 1.6%, its strongest performance since early August, while the Nasdaq advanced 2%. The Dow rose 1.1%, breaking a three-week losing streak. This resilience highlights the market’s underlying optimism, even as volatility creeps higher ahead of the Fed’s policy pivot.

On a broader scale, the U.S. Stock Market Index (US500) edged up to 6,588 points on September 12, marking a marginal 0.01% daily gain. The benchmark has risen 1.88% over the past month and stands 17.1% higher compared with a year ago. The index also touched a record intraday high of 6,603.16 this month, reflecting the powerful upward momentum fueled by both corporate earnings and rate-cut bets.

What Investors Should Watch Next

With markets already pricing in monetary easing, the risk lies in whether the Fed delivers enough stimulus to meet expectations. A cautious 25-basis-point cut may disappoint more aggressive traders, while a surprise half-point move could reignite concerns about the depth of economic weakness. Investor psychology will be key: optimism over lower borrowing costs must be balanced against fears of a sharper slowdown in hiring and growth.

Looking ahead, equity markets may remain in a tug-of-war between macroeconomic caution and sector-specific optimism. For U.S. and Israeli investors alike, the next phase of the rally hinges on whether policy support can sustain risk appetite in the face of an economy showing early signs of strain. The coming weeks will test whether Wall Street’s resilience marks the start of a new leg higher—or the last stretch before volatility returns.


Comparison, examination, and analysis between investment houses

Leave your details, and an expert from our team will get back to you as soon as possible

    * This article, in whole or in part, does not contain any promise of investment returns, nor does it constitute professional advice to make investments in any particular field.

    To read more about the full disclaimer, click here
    SKN | Amicus Therapeutics Surges Over 30% as Revenue Momentum and Earnings Visibility Reignite Investor Confidence
    • orshu
    • 6 Min Read
    • ago 41 minutes

    SKN | Amicus Therapeutics Surges Over 30% as Revenue Momentum and Earnings Visibility Reignite Investor Confidence SKN | Amicus Therapeutics Surges Over 30% as Revenue Momentum and Earnings Visibility Reignite Investor Confidence

      Amicus Therapeutics, Inc. (FOLD) rallied sharply during US trading, climbing over 30% to trade around USD 14.20, as investors

    • ago 41 minutes
    • 6 Min Read

      Amicus Therapeutics, Inc. (FOLD) rallied sharply during US trading, climbing over 30% to trade around USD 14.20, as investors

    SKN | Invesco QQQ Rallies as Nasdaq Strength Reinforces Mega-Cap Tech Leadership
    • orshu
    • 6 Min Read
    • ago 1 hour

    SKN | Invesco QQQ Rallies as Nasdaq Strength Reinforces Mega-Cap Tech Leadership SKN | Invesco QQQ Rallies as Nasdaq Strength Reinforces Mega-Cap Tech Leadership

      Invesco QQQ Trust (QQQ) traded firmly higher on December 19, 2025, rising 1.30% to USD 617.01 during active market

    • ago 1 hour
    • 6 Min Read

      Invesco QQQ Trust (QQQ) traded firmly higher on December 19, 2025, rising 1.30% to USD 617.01 during active market

    SKN | Nikkei 225 Climbs Above 49,500 as Japanese Stocks Extend Late-Year Momentum
    • orshu
    • 6 Min Read
    • ago 2 hours

    SKN | Nikkei 225 Climbs Above 49,500 as Japanese Stocks Extend Late-Year Momentum SKN | Nikkei 225 Climbs Above 49,500 as Japanese Stocks Extend Late-Year Momentum

      Japan’s Nikkei 225 closed higher on December 19, 2025, extending recent gains as investor confidence held steady into the

    • ago 2 hours
    • 6 Min Read

      Japan’s Nikkei 225 closed higher on December 19, 2025, extending recent gains as investor confidence held steady into the

    SKN | Can ‘Avatar: Fire and Ash’ Reignite the Global Box Office in a Changed Movie Market?
    • omer bar
    • 7 Min Read
    • ago 3 hours

    SKN | Can ‘Avatar: Fire and Ash’ Reignite the Global Box Office in a Changed Movie Market? SKN | Can ‘Avatar: Fire and Ash’ Reignite the Global Box Office in a Changed Movie Market?

    Disney and James Cameron’s “Avatar: Fire and Ash” entered theaters with $12 million in Thursday night preview screenings in the

    • ago 3 hours
    • 7 Min Read

    Disney and James Cameron’s “Avatar: Fire and Ash” entered theaters with $12 million in Thursday night preview screenings in the